1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Relationship Between Serotonin‐2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          There is growing evidence that the serotonergic system, in particular serotonin 2A receptors, is involved in neuropsychiatric symptoms in Parkinson's disease ( PD), including cognitive processing and visual hallucinations. However, the relationship between serotonin 2A receptor availability, visual hallucinations, and cognitive profile is unknown. The objective of this study was to investigate the level of serotonin 2A receptor availability in brain regions affected by visual hallucinations and to test the association with cognitive/behavioral changes in patients who have PD with visual hallucinations.

          Methods

          Nondemented patients who had PD with (n = 11) and without (n = 8) visual hallucinations and age‐matched controls (n = 10) were recruited. All participants completed neuropsychological testing, which consisted of visuoperceptual, executive, memory, language, and frontal‐behavioral function. Positron emission tomography scans using [ 18F]setoperone, a serotonin 2A antagonist radioligand, were acquired in patients with PD, and a parametric binding potential map of [ 18F]setoperone was calculated with the simplified reference tissue model using the cerebellum as a reference.

          Results

          Patients who had PD with visual hallucinations exhibited significantly lower scores on measures of executive and visuoperceptual functions compared with age‐matched controls. These changes were paralleled by decreased [ 18F]setoperone binding in the right insula, bilateral dorsolateral prefrontal cortex, right orbitofrontal cortex, right middle temporal gyrus, and right fusiform gyrus. The psychometric correlation analysis revealed significant relationships among tests associated with visuoperceptual function, memory and learning, and serotonin 2A binding in different prefrontal and ventral visual stream regions. There was also reduced serotonin 2A receptor binding in patients who had PD with depression.

          Conclusions

          These findings support a complex interaction between serotonin 2A receptor function and cognitive processing in patients who have PD with visual hallucinations.

          Related collections

          Author and article information

          Contributors
          sfox@uhnresearch.ca
          Journal
          Mov Disord Clin Pract
          Mov Disord Clin Pract
          10.1002/(ISSN)2330-1619
          MDC3
          Movement Disorders Clinical Practice
          John Wiley and Sons Inc. (Hoboken )
          2330-1619
          23 January 2017
          Sep-Oct 2017
          : 4
          : 5 ( doiID: 10.1002/mdc3.2017.4.issue-5 )
          : 698-709
          Affiliations
          [ 1 ] Division of Brain, Imaging and Behavior‐Systems Neuroscience Krembil Research Institute University Health Network University of Toronto Toronto Ontario Canada
          [ 2 ] Research Imaging Center Center for Addiction and Mental Health University of Toronto Toronto Ontario Canada
          [ 3 ] Movement Disorder Unit and E. J. Safra Parkinson Disease Program Toronto Western Hospital University Health Network University of Toronto Toronto Ontario Canada
          [ 4 ] Department of Psychiatry University of Toronto Toronto Ontario Canada
          [ 5 ] Division of Neurology Onze‐Lieve‐Vrouw Hospital Aalst Belgium
          Author notes
          [*] [* ] Correspondence to: Dr. Susan H. Fox, Movement Disorders Centre, Toronto Western Hospital, University Health Network, University of Toronto, Toronto Ontario, Canada M5T2S8; E‐mail: sfox@ 123456uhnresearch.ca
          Article
          PMC6174444 PMC6174444 6174444 MDC312466
          10.1002/mdc3.12466
          6174444
          30363421
          395c85ea-1152-4d9b-b932-79db3d5a6e8d
          © 2016 International Parkinson and Movement Disorder Society
          History
          : 15 August 2016
          : 10 November 2016
          : 01 December 2016
          Page count
          Figures: 4, Tables: 4, Pages: 12, Words: 8823
          Categories
          Research Article
          Research Articles
          Custom metadata
          2.0
          mdc312466
          September/October 2017
          Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.0 mode:remove_FC converted:08.10.2018

          serotonin 2A (5‐HT 2A) receptor,cognitive decline,Parkinson's disease,positron emission tomography (PET),visual hallucinations

          Comments

          Comment on this article